A detailed history of Thrivent Financial For Lutherans transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 214,645 shares of MRVI stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
214,645
Previous 187,760 14.32%
Holding current value
$1.21 Million
Previous $1.34 Million 32.74%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$6.84 - $9.73 $183,893 - $261,591
26,885 Added 14.32%
214,645 $1.78 Million
Q2 2024

Aug 13, 2024

BUY
$6.87 - $11.34 $81,574 - $134,651
11,874 Added 6.75%
187,760 $1.34 Million
Q1 2024

May 14, 2024

SELL
$5.11 - $8.76 $638,795 - $1.1 Million
-125,009 Reduced 41.55%
175,886 $1.53 Million
Q4 2023

Feb 14, 2024

SELL
$4.7 - $9.87 $54.2 Million - $114 Million
-11,537,474 Reduced 97.46%
300,895 $1.97 Million
Q3 2023

Nov 14, 2023

BUY
$9.14 - $12.85 $32.3 Million - $45.4 Million
3,533,237 Added 42.54%
11,838,369 $118 Million
Q2 2023

Aug 14, 2023

BUY
$12.09 - $15.0 $1.39 Million - $1.73 Million
115,334 Added 1.41%
8,305,132 $103 Million
Q1 2023

May 17, 2023

BUY
$12.99 - $16.48 $26.1 Million - $33.2 Million
2,011,683 Added 32.56%
8,189,798 $115 Million
Q4 2022

Feb 08, 2023

BUY
$12.5 - $24.78 $45.2 Million - $89.7 Million
3,618,369 Added 141.36%
6,178,115 $88.4 Million
Q3 2022

Nov 14, 2022

BUY
$20.6 - $30.37 $52.7 Million - $77.7 Million
2,559,746 New
2,559,746 $65.4 Million
Q1 2022

May 13, 2022

SELL
$24.46 - $40.92 $510,088 - $853,345
-20,854 Closed
0 $0
Q4 2021

Feb 16, 2022

BUY
$35.0 - $45.94 $729,890 - $958,032
20,854 New
20,854 $874,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $739M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.